Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...
Hosted on MSN9h
10 Ways New Discoveries Are Helping Us Save Endangered Animals
Recent advancements in genetic research are proving instrumental in the conservation of endangered species. Scientists are ...
The Peninsula22hOpinion
The elixir of life: When AI meets genomics
The revolution in artificial intelligence (AI) and genetic engineering represents an unprecedented turning point in human ...